TrialJournal for immunotherapy of cancer2021

Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial.

Robert L Ferris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.